RRC ID 47246
Author Konno A, Nishimura A, Nakamura S, Mochizuki A, Yamada A, Kamijo R, Inoue T, Iijima T.
Title Continuous monitoring of caspase-3 activation induced by propofol in developing mouse brain.
Journal Int J Dev Neurosci
Abstract The neurotoxicity of anesthetics on the developing brain has drawn the attention of anesthesiologists. Several studies have shown that apoptosis is enhanced by exposure to anesthesia during brain development. Although apoptosis is a physiological developmental step occurring before the maturation of neural networks and the integration of brain function, pathological damage also involves apoptosis. Previous studies have shown that prolonged exposure to anesthetics causes apoptosis. Exactly when the apoptotic cascade starts in the brain remains uncertain. If it starts during the early stage of anesthesia, even short-term anesthesia could harm the brain. Therefore, apoptogenesis should be continuously monitored to elucidate when the apoptotic cascade is triggered by anesthesia. Here, we describe the development of a continuous monitoring system to detect caspase-3 activation using an in vivo model. Brain slices from postnatal days 0-4 SCAT3 transgenic mice with a heterozygous genotype (n=20) were used for the monitoring of caspase-3 cleavage. SCAT3 is a fusion protein of ECFP and Venus connected by a caspase-3 cleavable peptide, DEVD. A specimen from the hippocampal CA1 sector was mounted on a confocal laser microscope and was continuously superfused with artificial cerebrospinal fluid, propofol (2,6-diisopropylphenol, 1μM or 10μM), and dimethyl sulfoxide. Images were obtained every hour for five hours. A pixel analysis of the ECFP/Venus ratio images was performed using a histogram showing the number of pixels with each ratio. In the histogram of the ECFP/Venus ratio, an area with a ratio>1 indicated the number of pixels from caspase-3-activated CA1 neurons. We observed a shift in the histogram toward the right over time, indicating caspase-3 activation. This right-ward shift dramatically changed at five hours in the propofol 1μM and 10μM groups and was obviously different from that in the control group. Thus, real-time fluorescence energy transfer (FRET) imaging was capable of identifying the onset of apoptosis triggered by propofol in neonatal brain slices. This model may be a useful tool for monitoring apoptogenesis in the developing brain.
Volume 51
Pages 42-9
Published 2016-6-1
DOI 10.1016/j.ijdevneu.2016.04.007
PII S0736-5748(16)30026-0
PMID 27126009
MeSH Animals Animals, Newborn Apoptosis / drug effects Apoptosis / genetics CA1 Region, Hippocampal / cytology CA1 Region, Hippocampal / drug effects* CA1 Region, Hippocampal / growth & development* Caspase 3 / genetics Caspase 3 / metabolism* Dose-Response Relationship, Drug Fluorescence Resonance Energy Transfer Gene Expression Regulation, Developmental / drug effects Green Fluorescent Proteins / genetics Green Fluorescent Proteins / metabolism HeLa Cells Humans Hypnotics and Sedatives / pharmacology* In Vitro Techniques Mice Mice, Inbred C57BL Mice, Transgenic Neurons / drug effects Propofol / pharmacology* Transfection
IF 1.911
Times Cited 4
Mice RBRC03114